Premenstrual Syndrome Treatment Market
Premenstrual Syndrome Treatment Market

Market Insights and Analysis: Premenstrual Syndrome Treatment Market Overview and Projections (2024-2030)

The Global Premenstrual Syndrome Treatment Market is estimated to grow at a CAGR of around 3.7% during the forecast period, i.e., 2024-30.

Top leading companies in the Premenstrual Syndrome Treatment Market includes:

Bayer AG, Pfizer Inc., Zydus Cadila, Alkem Laboratories Ltd., Kobayashi Pharmaceutical Co., Ltd., Haleon Group of Companies, Johnson & Johnson Services, Inc., Teva Pharmaceutical Industries Ltd., Viatris Inc., Asarina Pharma AB, Lupin, Sun Pharmaceutical Industries Ltd., Intas Pharmaceuticals Ltd. (Accord Healthcare), Ova Moon, AstraZeneca plc, and others

Industry Recent Development:

  • 2022: Lupin received the US Food and Drug Administration approval for the generic oral contraceptive pill Drospirenone.

Access the detailed PDF Sample report https://www.marknteladvisors.com/query/request-sample/premenstrual-syndrome-treatment-market.html

Report Segmentation:

The market is categorized into the following segments in the report:

By Drug Type

-Analgesics

-Antidepressants

-Oral Contraceptives

-Ovarian Suppression Agents

-Others (Diuretics, Herbal Supplements, etc.)

  • the oral contraceptives segment held a major market share.

By Type

-Prescription

-Over-the-Counter (OTC)

By Distribution Channel

-Hospital Pharmacies

-Retail Pharmacies

-Online Pharmacies)

Explore Our Comprehensive Study Reports –  https://www.marknteladvisors.com/research-library/premenstrual-syndrome-treatment-market.html                             

Premenstrual Syndrome Treatment Market Geographic Reach:

The Geographic Reach of the Premenstrual Syndrome Treatment Market evaluates the spread and significance of Premenstrual Syndrome Treatment market consumption across different regions/country, emphasizing areas with the largest market size and the most promising growth potential.

  • North America: The US, Canada, Mexico
  • Europe: Germany, The UK, France, Italy, Spain, Rest of Europe
  • Asia-Pacific: China, Japan, Australia, South Korea, India, Rest of Asia-Pacific
  • South America: Brazil, Rest of South Americ
  • Middle East & Africa: The UAE, South Africa, Saudi Arabia, Rest of the Middle East & Africa

Note: If you require specific information not covered in the current report, we can provide it through customized option

Related Reports: –

https://www.openpr.com/news/3571362/carbon-credit-trading-market-trend-size-growth-top-companies     

https://www.openpr.com/news/3522730/shipping-container-market-reaches-usd-10-5-billion-worth     

https://www.openpr.com/news/3522720/poppy-seed-market-hits-usd-203-million-worth-in-2023-and-till-2030     

https://www.openpr.com/news/3489091/global-flying-car-market-forecasts-37-80-cagr-growth-over     

https://www.openpr.com/news/3489077/global-cartilage-repair-and-regeneration-market-forecasts     

Why choose Us?

MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.

For Media Inquiries, Please Contact:

Call: +1 628 895 8081 | +91 120 4278433

Email: sales@marknteladvisors.com

Sales Office: 564 Prospect St, B9, New Haven, Connecticut, USA-06511

Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India

steve

Leave a Reply

Your email address will not be published. Required fields are marked *